Dr. Narinder Grewal, MD, and the Team at Advanced Pain Management and Neurology Clinic are Proud to Introduce LASE
Dr. Narinder Grewal, MD has made a name for himself in the field of interventional pain management. For over twenty...
Day: September 9, 2019
Implanet Reports Dramatic Improvement in First-half Earnings
Gross margin up 8% Operating loss significantly reduced by 44% to €1.55 million BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET...
Medical Marijuana Company Plans Further Expansion in Florida
JACKSONVILLE, FL / ACCESSWIRE / September 9, 2019 / Liberate Physician Centers, a leading provider of medical marijuana certifications with...
Champions Oncology to Announce First Quarter Financial Results on Monday, September 16, 2019
HACKENSACK, NJ / ACCESSWIRE / September 9, 2019 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research...
Jaguar Health Promotes Jonathan Wolin to Chief of Staff, Chief Compliance Officer & General Counsel
SAN FRANCISCO, CA / ACCESSWIRE / September 9, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) announced today...
AIM ImmunoTech Inc. Announces its Name Change is Complete, Its New Website is Up and the Company Now Trades as Ticker Symbol ‘AIM’
OCALA, FL / ACCESSWIRE / September 9, 2019 / AIM ImmunoTech Inc. (NYSE American:AIM) announced today that its name change...
Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3®
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today three additional indices (delta cHb, delta HHb, and delta O2Hb) for O3® Regional...
Clinical Innovations’ Ken Reali to Deliver Keynote at APEC forum
Medical device leader will discuss ‘tone at the top’ before large, international audience SALT LAKE CITY--(BUSINESS WIRE)--Ken Reali, president and...
Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System
Company to host conference call and webcast at 9:00 am EDT Today IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX),...
Odyssey and Prevacus Expand Partnership for Rare Brain Disorders
The Joint Venture will Develop the Compound PRV-001 for Multiple Leukodystrophies IRIVINE, CA / ACCESSWIRE / September 9, 2019 /...